Saturday, March 2, 2024



European Commission Approves Beta Thalassemia Treatment CASGEVY

Vertex Pharmaceuticals Incorporated has reached a significant achievement in the realm of severe sickle cell disease and beta thalassemia treatment with the European Commission...

European Approval Secured by Vertex for Cystic Fibrosis Medicine

Vertex Pharmaceuticals achieved a significant milestone in July 2023 when the European Commission granted an expanded label for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) with ivacaftor, specifically for...

Latest news

Sticky Image